Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Authors

Xiuning Le
Eric Nadler
Daniel B Costa
John Victor Heymach

Language

English

Publication Date

1-1-2024

Journal

Targeted Oncology

DOI

10.1007/s11523-023-01020-1

PMID

38070005

PMCID

PMC10830660

PubMedCentral® Posted Date

12-9-2023

PubMedCentral® Full Text Version

Post-print

Comments

This corrects the article "EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast" in volume 18 on page 807.

Published Open-Access

yes

Recommended Citation

Le, Xiuning; Nadler, Eric; Costa, Daniel B; et al., "Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast" (2024). Faculty, Staff and Student Publications. 5830.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5830